Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05388604
Other study ID # MD-PM01-2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 15, 2022
Est. completion date August 29, 2023

Study information

Verified date October 2023
Source Cynosure, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The intended use of the radiofrequency and microneedling devices used in this study is to assess the efficacy and safety of paired treatment for the treatment of facial aging.


Description:

Subjects are to be enrolled in this clinical study if they are a healthy male or female 40 - 65 years of age. Up to 35 subjects will be enrolled at 2 study centers. Subjects will attend a screening/pretreatment visit which may be performed on the same day as the treatment visit. Subjects may receive up to 4 treatments on the face.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date August 29, 2023
Est. primary completion date August 29, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria: - A healthy male or female between the age of 40 - 65 years old. - Diagnosed with clinically evident moderate wrinkles and/or moderate photoaging, including but not limited to dyschromia, and willing to undergo treatments with the study devices. - Understands and accepts obligation not to receive any other procedures on the treatment area through the length of the study. - Understands and accepts the obligation and is logistically able to be present for all visits. - Is willing to comply with all requirements of the study and sign the informed consent document. Exclusion Criteria: - The subject is pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study. - The subject is hypersensitive to light in the near infrared wavelength region. - The subject is taking medication which is known to increase sensitivity to sunlight. - The subject has a seizure disorders triggered by light. - The subject is taking or have taken oral isotretinoin, such as Accutane®, within the last six months. - The subject has an active localized or systemic infection, or an open wound in area being treated. - The subject has a significant systemic illness, such as lupus, or an illness localized in area being treated. - The subject has active herpes simplex in the area being treated. - The subject is receiving or have received gold therapy. - The subject has a pacemaker. - The subject has a metal implant that interferes with the transmission of energy to the electrical field. - The subject has any embedded electronic devices that give or receive a signal such as Implantable Cardiac Defibrillators (ICD) or Cardiac Resynchronization Therapy (CRT) devices: treatment may interfere with the functionality of the device and/or damage the electronic implant. - The subject is allergic to adhesives such as glues on medical tape. - The subject is allergic to gold. - The subject has nerve insensitivity to heat in the treatment area or in the neutral pad placement area or a neuropathic disorder. - The subject has severe laxity or sagging that causes redundant folds of tissue or hanging skin in the area to be treated - The subject is taking aspirin or are currently taking antiplatelets, thrombolytics, anti-inflammatories or anticoagulants. - The subject has a history of bleeding coagulopathies. - The subject is allergic to topical anesthetic. - The subject has any of the following conditions: - Uncontrolled diabetes - Epilepsy - Autoimmune disease - HIV - Uncontrolled hypertension - The subject has keloid formation propensity. - The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within the area to be treated 6 months (or at the discretion of the Investigator) prior to entering this study. - The subject has any condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation. Cautionary Criteria: - The subject has had unprotected sun exposure within four weeks of treatment, including the use of tanning beds or tanning products, such as creams, lotions, and sprays. - The subject has a history of immunosuppression/immune deficiency or an auto-immune disorder. - The subject is taking medications that alter the wound-healing response or evidence of compromised wound healing. - The subject has a history of skin cancer or suspicious lesions in the treatment area. - The subject has used retinoids in the last seven days in the area to be treated. - The subject has used any chemical peels in the last three months in the treatment area. - The subject has tattoos, permanent makeup, and permanent brows in the treatment area. - The subject has received fillers or neurotoxin injections in the last two weeks.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
RF device
The entire defined treatment area will then be treated by delivering adjacent pulses with minimal overlap of 10% or less. Parameters may be adjusted throughout the treatment in order to increase subject comfort.
Microneedling device
Test spots may be performed prior to the first treatment. Test spots may be performed prior to the first treatment. It will follow a similar procedure to treatment but only in an inconspicuous place, such as behind the ear, in an area no larger than 2in x 2in. The tip will be placed in contact with the skin, and parameters may be adjusted throughout the treatment and will determined by the Clinician.

Locations

Country Name City State
United States New Jersey Plastic Surgery Montclair New Jersey
United States Laser & Skin Surgery Center of New York New York New York
United States Center for Dermatology and Laser Surgery Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
Cynosure, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent of Photos Identified Correctly of 30 Day Follow Up vs. Baseline The percent of correctly identified photographs (when comparing baseline photos vs. 30 day follow up photos) will be reported. 30 day follow up
Primary Percent of Photos Identified Correctly of 90 Day Follow Up vs. Baseline The percent of correctly identified photographs (when comparing baseline photos vs. 90 day follow up photos) will be reported. 90 day follow up
See also
  Status Clinical Trial Phase
Completed NCT05098912 - Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction N/A
Completed NCT05271136 - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum N/A
Completed NCT05096247 - Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device N/A
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT04128046 - The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation N/A
Active, not recruiting NCT04727099 - Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™ N/A
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Not yet recruiting NCT05524779 - BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement N/A
Completed NCT05514782 - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum N/A
Completed NCT06123572 - A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel N/A
Completed NCT04911374 - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream N/A
Recruiting NCT04989361 - Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles. N/A
Recruiting NCT04540900 - A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions Phase 1
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Active, not recruiting NCT06219278 - A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles N/A
Active, not recruiting NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System N/A
Completed NCT04650620 - Study to Evaluate the Performance and Safety of the Medical Device Plenhyage® N/A
Completed NCT03729700 - The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome N/A